Who invested in Ternary Therapeutics?
Ternary Therapeutics's investors include Daphni.

United Kingdom · Seed startup
Funding summaryUpdated 26 Oct 2026
$9.1Mraised across 3 rounds since 2024, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Ternary Therapeutics filed 3 raises, $5.3M in all. Filings say how much was sold and to how many investors; they never name the investors.
From Ternary Therapeutics's own website: 2 founders, 1 on the team.
Ternary Therapeutics's investors include Daphni.
Ternary Therapeutics has raised $9.1M across 3 rounds since 2024.
Ternary Therapeutics's most recent round was a Seed of $4.8M in Mar 2026.
Its most recent round, $4.8M in Mar 2026, is also its largest on record.
Ternary Therapeutics's first round on record, in Mar 2026, was backed by Daphni.
Ternary Therapeutics's latest named round is a Seed, in Mar 2026.
Ternary Therapeutics is based in the United Kingdom.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.